COLGATE-PALMOLIVE CO (CL) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:CL - US1941621039 - Common Stock
84.52 USD
+0.18 (+0.21%)
83.76 USD
-0.76 (-0.9%)
ChartMill assigns a Buy % Consensus number of 73% to CL. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 89.06. This target is 5.37% above the current price.
- CL was analyzed by 30 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about CL.
- In the previous month the buy percentage consensus was at a similar level.
- CL was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-14 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2026-01-08 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-07 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-12-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-11 | Argus Research | Downgrade | Buy -> Hold |
| 2025-12-09 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2025-11-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-03 | UBS | Maintains | Buy -> Buy |
| 2025-11-03 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-11-03 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-20 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-08 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | B of A Securities | Maintains | Buy -> Buy |
| 2025-10-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-01 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-25 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-08-04 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-08-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-04 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-17 | UBS | Maintains | Buy -> Buy |
| 2025-07-15 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-28 | JP Morgan | Maintains | Overweight -> Overweight |
COLGATE-PALMOLIVE CO / CL FAQ
Can you provide the average price target for COLGATE-PALMOLIVE CO stock?
30 analysts have analysed CL and the average price target is 89.06 USD. This implies a price increase of 5.37% is expected in the next year compared to the current price of 84.52.
How do analysts rate COLGATE-PALMOLIVE CO (CL)?
The consensus rating for COLGATE-PALMOLIVE CO (CL) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.